MUT expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 8.942200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
7.130200E-01
Normal-vs-Stage2
8.120400E-01
Normal-vs-Stage3
1.104010E-01
Normal-vs-Stage4
3.332200E-01
Stage1-vs-Stage2
4.777200E-01
Stage1-vs-Stage3
1.114630E-01
Stage1-vs-Stage4
7.560200E-01
Stage2-vs-Stage3
5.948400E-02
Stage2-vs-Stage4
6.360400E-02
Stage3-vs-Stage4
8.563900E-03
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
8.404600E-01
Normal-vs-AfricanAmerican
4.785200E-01
Normal-vs-Asian
8.031600E-01
Caucasian-vs-AfricanAmerican
1.153220E-01
Caucasian-vs-Asian
8.103200E-01
AfricanAmerican-vs-Asian
2.275400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
8.536000E-01
Normal-vs-Female
9.432600E-01
Male-vs-Female
6.776400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
5.527000E-01
Normal-vs-Age(41-60Yrs)
7.956000E-01
Normal-vs-Age(61-80Yrs)
6.917400E-01
Normal-vs-Age(81-100Yrs)
9.593000E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
3.928200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
7.174200E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.921600E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
3.121800E-02
Age(41-60Yrs)-vs-Age(81-100Yrs)
5.626800E-01
Age(61-80Yrs)-vs-Age(81-100Yrs)
7.113800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.945800E-01
Normal-vs-Daily Drinker
2.741200E-01
Normal-vs-Weekly Drinker
5.670200E-01
Normal-vs-Occasional Drinker
6.726200E-01
Normal-vs-Social Drinker
8.277200E-01
Non Drinker-vs-Daily Drinker
2.136000E-01
Non Drinker-vs-Weekly Drinker
9.931600E-01
Non Drinker-vs-Occasional Drinker
6.441600E-02
Non Drinker-vs-Social Drinker
1.636810E-01
Daily Drinker-vs-Weekly Drinker
3.431000E-01
Daily Drinker-vs-Occasional Drinker
9.756100E-03
Daily Drinker-vs-Social Drinker
2.839800E-02
Weekly Drinker-vs-Occasional Drinker
1.125250E-01
Weekly Drinker-vs-Social Drinker
2.174600E-01
Occasional Drinker-vs-Social Drinker
6.732000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
1.991200E-01
Normal-vs-Grade 2
6.192100E-02
Normal-vs-Grade 3
5.751600E-02
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
6.060200E-01
Grade 1-vs-Grade 3
7.557400E-01
Grade 1-vs-Grade 4
1.991200E-01
Grade 2-vs-Grade 3
7.448800E-01
Grade 2-vs-Grade 4
6.192100E-02
Grade 3-vs-Grade 4
5.751600E-02
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
7.098400E-01
Normal-vs-NonDiabetic
7.778000E-01
Diabetic-vs-NonDiabetic
5.837800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
4.116800E-01
Normal-vs-NoPancreatitis
8.207800E-01
Pancreatitis-vs-NoPancreatitis
3.165400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
9.912000E-01
Normal-vs-N1
8.162000E-01
N0-vs-N1
5.446600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
9.585400E-01
Normal-vs-TP53-NonMutant
6.984000E-01
TP53-Mutant-vs-TP53-NonMutant
1.950770E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
